This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Merritt, R. J. Articles by Olson, D. Search for Related Content PubMed PubMed Citation Articles by Merritt, R. J. Articles by Olson, D. Social Bookmarking                         What's this?

Corticosteroid Therapy-induced Obesity in Children

Childrens Hospital of Los Angeles, School of Medicine, University of Southern California, Los Angeles, California

Shirley L. Hack

Childrens Hospital of Los Angeles, School of Medicine, University of Southern California, Los Angeles, California

Maryse Kalsch

Childrens Hospital of Los Angeles, School of Medicine, University of Southern California, Los Angeles, California

David Olson

Childrens Hospital of Los Angeles, School of Medicine, University of Southern California, Los Angeles, California

The severity and persistence of corticosteroid-induced obesity were evaluated retrospectively in 23 children aged 1-14 yrs requiring more than 60 days of therapy with prednisone for idiopathic nephrotic syndrome. Mean relative weight (after clearing of proteinuria) at initiation of therapy was 107 ± 10 percent. Peak relative weight on therapy was 119 ± 15 percent following a mean total of 31 months of cumulative steroid therapy. The most recent available relative weight in remission at least 6 months following cessation of therapy was 107 ± 18 percent. The number of children whose relative weight exceeded 120 percent at initiation of, during and following therapy was 3, 10, and 4, respectively. In those with normal initial relative weight (<110%) there was no persistent obesity. Two of three initially obese patients (relative weight > 120%) remained obese. All patients with persistent obesity following therapy had initial relative weight of at least 110 percent and peak relative weight of more than 130 percent. The risk of persistent obesity as a result of chronic corticosteroid therapy in initially normal weight children who do not exceed 130 percent relative weight during therapy appears to be small.

Clinical Pediatrics, Vol. 25, No. 3, 149-152 (1986)
DOI: 10.1177/000992288602500304


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. S. Gipson, S. F. Massengill, L. Yao, S. Nagaraj, W. E. Smoyer, J. D. Mahan, D. Wigfall, P. Miles, L. Powell, J.-J. Lin, et al. Management of Childhood Onset Nephrotic Syndrome Pediatrics, August 1, 2009; 124(2): 747 - 757. [Abstract] [Full Text] [PDF]

				A.Y. Elzouki and O.P. Jaiswal Long-term, Small Dose Prednisone Therapy in Frequently Relapsing Nephrotic Syndrome of Childhood: Effect on Remission, Statural Growth, Obesity, and Infection Rate Clinical Pediatrics, August 1, 1988; 27(8): 387 - 392. [Abstract] [PDF]